Compared to Estimates, Merck (MRK) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/04/26
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal chargesCNBC • 08/04/26
The Merck Product That Absolutely Demolished Wall Street's ForecastsInvestors Business Daily • 08/04/26
Merck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street?Barrons • 08/04/26
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse PipelineBusiness Wire • 08/04/26
Merck & Co., Inc. (MRK) Discusses HIV Program Updates and Phase III Data from International AIDS Conference TranscriptSeeking Alpha • 08/03/26
Merck: Heading Into Q2 Earnings, The Keytruda Cliff Looks Increasingly Less SteepSeeking Alpha • 07/31/26
Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPSZacks Investment Research • 07/30/26
Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trialsReuters • 07/30/26
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 DevelopmentBusiness Wire • 07/24/26
Will Keytruda Remain the Driving Force Behind Merck's Q2 Performance?Zacks Investment Research • 07/22/26
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?Zacks Investment Research • 07/21/26